Abstract
The mouse has proven to be an excellent model for testing apolipoprotein mimetic peptides as agents to treat a variety of vascular inflammatory conditions including atherosclerosis, cognitive dysfunction associated with arteriole inflammation, chronic rejection of transplanted hearts, and scleroderma. The mechanism of action appears to relate to the ability of these peptides to preferentially bind pro-inflammatory oxidized lipids and is independent of the chirality of the peptides since peptides synthesized from either D- or L-amino acids appear to be equally effective.
Current Drug Targets
Title: Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models
Volume: 9 Issue: 3
Author(s): Mohamad Navab, G. M. Anantharamaiah, Srinivasa T. Reddy, Brian J. Van Lenten and Alan M. Fogelman
Affiliation:
Abstract: The mouse has proven to be an excellent model for testing apolipoprotein mimetic peptides as agents to treat a variety of vascular inflammatory conditions including atherosclerosis, cognitive dysfunction associated with arteriole inflammation, chronic rejection of transplanted hearts, and scleroderma. The mechanism of action appears to relate to the ability of these peptides to preferentially bind pro-inflammatory oxidized lipids and is independent of the chirality of the peptides since peptides synthesized from either D- or L-amino acids appear to be equally effective.
Export Options
About this article
Cite this article as:
Navab Mohamad, Anantharamaiah M. G., Reddy T. Srinivasa, Van Lenten J. Brian and Fogelman M. Alan, Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models, Current Drug Targets 2008; 9 (3) . https://dx.doi.org/10.2174/138945008783755584
DOI https://dx.doi.org/10.2174/138945008783755584 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Vascular Disease in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Endothelial Cells in Inflammation and Angiogenesis
Current Drug Targets - Inflammation & Allergy Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Pulmonary Hypertension and Lung Transplantation
Current Hypertension Reviews Central Nervous System Involvement in Pediatric Rheumatic Diseases: Current Concepts in Treatment
Current Pharmaceutical Design The Role of Zinc in the Treatment of Taste Disorders
Recent Patents on Food, Nutrition & Agriculture Subject Index to Volume 3
Mini-Reviews in Medicinal Chemistry Th17 Cells: The Role in Immunity
Current Immunology Reviews (Discontinued) Scleroderma-like Disorders
Current Rheumatology Reviews Pathogenesis and Therapeutics of Interstitial Lung Disease in Systemic Sclerosis
Current Rheumatology Reviews Clinical Experience with Specific COX-2 Inhibitors in Arthritis
Current Pharmaceutical Design TGF Beta Inhibition for Cancer Therapy
Current Cancer Drug Targets Systemic Lupus Erythematosus-Related Interstitial Lung Disease
Current Rheumatology Reviews Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
Current Pharmaceutical Design Biopharmaceutical Therapeutics for Asthma Remodeling
Current Pharmaceutical Design Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues
Anti-Cancer Agents in Medicinal Chemistry History and Milestones of Mouse Models of Autoimmune Diseases
Current Pharmaceutical Design Anti-Arthritic Effects of Immunomodulatory Peptide Injected in Joints
Current Drug Delivery Intravenous Immunoglobulin (IVIG) in Rheumatologic Diseases: A Review of its Mechanism of Action
Current Rheumatology Reviews The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis